14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Feb 22, 2024 Buy 150 000 White Debra Employee stock option (right to buy)
Feb 22, 2024 Buy 150 000 Sparks Ronald M Employee stock option (right to buy)
Feb 22, 2024 Buy 150 000 Lapidus Stanley Employee stock option (right to buy)
Feb 22, 2024 Buy 150 000 Cox James L Employee stock option (right to buy)
Feb 22, 2024 Buy 150 000 Sokolov Jacque J Employee stock option (right to buy)
Feb 15, 2024 Sell 3 331 747 Pavmed Inc. Common Stock
Jan 26, 2024 Buy 3 331 771 Pavmed Inc. Common Stock
Sep 26, 2023 Sell 10 000 Lapidus Stanley Common stock
Sep 26, 2023 Sell 10 000 Lapidus Stanley Common stock
Sep 26, 2023 Sell 9 747 Lapidus Stanley Common stock
Sep 25, 2023 Sell 200 Lapidus Stanley Common stock
Sep 21, 2023 Sell 100 Lapidus Stanley Common stock
Sep 21, 2023 Sell 100 Lapidus Stanley Common stock
Sep 20, 2023 Sell 3 405 Lapidus Stanley Common stock
Sep 20, 2023 Sell 412 Lapidus Stanley Common stock
Sep 20, 2023 Sell 3 405 Lapidus Stanley Common stock
Sep 20, 2023 Sell 412 Lapidus Stanley Common stock
Jan 31, 2023 Buy 175 000 Sparks Ronald M Employee stock option (right to buy)
Jan 31, 2023 Buy 175 000 White Debra Employee stock option (right to buy)
Jan 31, 2023 Buy 175 000 Sokolov Jacque J Employee stock option (right to buy)
Jan 31, 2023 Buy 175 000 Lapidus Stanley Employee stock option (right to buy)
Jan 31, 2023 Buy 175 000 Cox James L Employee stock option (right to buy)
Nov 30, 2022 Buy 1 479 326 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 331 210 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 221 952 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 197 656 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 1 145 086 Pavmed Inc. Common stock
Nov 30, 2022 Buy 1 479 326 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 331 210 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 221 952 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 197 656 Pavmed Inc. Common Stock
Nov 30, 2022 Buy 1 145 086 Pavmed Inc. Common stock
Sep 20, 2022 Sell 17 000 Lapidus Stanley Common stock
Sep 20, 2022 Sell 16 864 Lapidus Stanley Common stock
Aug 02, 2022 Buy 80 000 White Debra Employee stock option (right to buy)
Aug 01, 2022 Buy 0 White Debra
Jun 07, 2022 Buy 200 000 Gordon Michael Adam Employee stock option (right to buy)
May 31, 2022 Buy 0 Gordon Michael Adam
Mar 18, 2022 Buy 0 O'neil Shaun Common stock
Mar 18, 2022 Buy 50 000 O'neil Shaun Employee stock option (right to buy)
Feb 18, 2022 Buy 59 000 Sokolov Jacque J Employee stock option (right to buy)
Feb 18, 2022 Buy 59 000 Angagaw Aster Employee stock option (right to buy)
Feb 18, 2022 Buy 59 000 Lapidus Stanley Employee stock option (right to buy)
Feb 18, 2022 Buy 59 000 Cox James L Employee stock option (right to buy)
Feb 18, 2022 Buy 59 000 Sparks Ronald M Employee stock option (right to buy)
Feb 18, 2022 Buy 50 000 Mcgrath Dennis M Employee stock option (right to buy)
Feb 18, 2022 Buy 75 000 Aklog Lishan Employee stock option (right to buy)
Jan 07, 2022 Buy 60 000 Mcgrath Dennis M Common stock
Jan 07, 2022 Buy 60 000 Aklog Lishan Common stock
Oct 18, 2021 Buy 84 660 Sparks Ronald M Common stock
Oct 18, 2021 Buy 571 428 Pavmed Inc. Common stock
Oct 13, 2021 Buy 0 Cox James L Common stock
Oct 13, 2021 Buy 0 Sparks Ronald M
Oct 13, 2021 Buy 0 Angagaw Aster Common stock
Oct 13, 2021 Buy 0 Lapidus Stanley Common stock
Oct 13, 2021 Buy 705 500 Wurtman David F Employee stock option (right to buy)
Oct 13, 2021 Buy 0 Sokolov Jacque J Common stock
Oct 13, 2021 Buy 0 Mcgrath Dennis M Common stock
Oct 13, 2021 Buy 0 Aklog Lishan Common stock
Oct 13, 2021 Buy 0 Pavmed Inc. Common stock
INSIDER POWER
29.935
Last 60 transactions
Buy: 13 938 819 | Sell: 3 403 392 (Shares)

Based on the 60 latest insides trades, we have calculated the insider power to be positive at a ratio of 29.935.

In total, the insiders bought 13 938 819 and sold 3 403 392 LUCD shares in the last 60 trades.

Click to get the best stock tips daily for free!

About Lucid Diagnostics Inc.

Lucid Diagnostics. Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an... LUCD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT